RTI Surgical Announces Agreement to Supply Complete Surgical Specialties Portfolio to Yankee Alliance Members
RTI Surgical Inc., a leading global surgical implant company, announced a new agreement with Yankee Alliance, a group purchasing organization with more than 14,700 members. The agreement covers RTI’s complete line of surgical specialties implants and is effective starting Jan. 1, 2014 for a term of three years.
RTI is the only provider with a comprehensive biologic solutions portfolio for use in hernia repair. The portfolio includes Fortiva™ porcine dermis, Cortiva™ human dermis, Tutopatch™ bovine pericardium and Tutomesh™ fenestrated bovine pericardium.
The surgical specialties implants are sterilized through the patented Tutoplast® Tissue Sterilization Process, a validated chemical sterilization process that thoroughly penetrates tissue, removing antigenicity and inactivating pathogens. Terminal sterilization using low dose gamma irradiation achieves a sterility assurance level (SAL) of 10 -6.
“We are pleased to announce this agreement with Yankee Alliance,” said Brian K. Hutchison, president and chief executive officer. “We look forward to offering their members our complete portfolio of surgical specialties implants which are backed by our stellar safety record of more than five million implants sterilized with zero incidence of implant-associated infection.” “We are always looking for ways to drive costs down in our member facilities and are excited to bring this affordable, high quality aggregated contract from RTI to our members,” said Craig Shoukimas, vice president of contracting at Yankee Alliance.
For more information about RTI’s comprehensive line of biologic implants used in hernia repair procedures, please visit www.rtisurgical.com or contact an RTI representative at (877) 612-4287.